Stifel Financial
AXSM icon

Stifel Financial’s Axsome Therapeutics AXSM Stock Holding History

Stifel Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1M Buy
5,920
+52
+0.9% +$8.98K ﹤0.01% 2460
2025
Q4 		$1.07M Buy
5,868
+361
+7% +$50.4K ﹤0.01% 2399
2025
Q3 		$669K Buy
5,507
+1,185
+27% +$133K ﹤0.01% 2637
2025
Q2 		$451K Buy
+4,322
New +$458K ﹤0.01% 2836
2021
Q3 		– Sell
-406,935
Closed -$27.5M – 3334
2021
Q2 		$27.5M Buy
406,935
+136
+0% +$8.16K 0.04% 363
2021
Q1 		$23M Buy
406,799
+769
+0.2% +$54.1K 0.04% 391
2020
Q4 		$33.1M Sell
406,030
-538
-0.1% -$40.2K 0.06% 285
2020
Q3 		$29M Sell
406,568
-30
-0% -$2.34K 0.06% 280
2020
Q2 		$33.5M Buy
406,598
+2,453
+0.6% +$189K 0.08% 238
2020
Q1 		$23.8M Hold
404,145
– – 0.07% 256
2019
Q4 		$41.8M Hold
404,145
– – 0.09% 225
2019
Q3 		$8.18M Sell
404,145
-374
-0.1% -$9.61K 0.02% 637
2019
Q2 		$10.4M Buy
404,519
+374
+0.1% +$7.5K 0.03% 558
2019
Q1 		$5.75M Hold
404,145
– – 0.02% 754
2018
Q4 		$1.14M Hold
404,145
– – ﹤0.01% 1449
2018
Q3 		$1.39M Hold
404,145
– – ﹤0.01% 1466
2018
Q2 		$1.29M Hold
404,145
– – ﹤0.01% 1456
2018
Q1 		$990K Sell
404,145
-11,134
-3% -$33.3K ﹤0.01% 1568
2017
Q4 		$2.33M Hold
415,279
– – 0.01% 1082
2017
Q3 		$2.31M Hold
415,279
– – 0.01% 1046
2017
Q2 		$2.28M Hold
415,279
– – 0.01% 1040
2017
Q1 		$1.62M Hold
415,279
– – 0.01% 1178
2016
Q4 		$2.8M Hold
415,279
– – 0.01% 893
2016
Q3 		$3.27M Buy
+415,279
New +$3.14M 0.01% 796

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Financial's AXSM Position: Q1 2026 in Review

Stifel Financial increased its Axsome Therapeutics (AXSM) stake by 0.89% in Q1 2026, buying an estimated $8.98K and bringing the position to 5,920 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2460.

Stifel Financial first reported a position in AXSM in Q3 2016 and has held it in 24 quarters since. The position peaked at $41.8M in Q4 2019. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Stifel Financial held 5,920 shares of Axsome Therapeutics worth $1M as of Q1 2026.
  • Stifel Financial bought 52 Axsome Therapeutics shares in Q1 2026, an estimated $8.98K.
  • Axsome Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2460 holding.
  • Stifel Financial first reported a position in Axsome Therapeutics in Q3 2016 and has held it in 24 quarters since.
  • Stifel Financial's Axsome Therapeutics position peaked at $41.8M in Q4 2019.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.